comparemela.com

Latest Breaking News On - Context therapeutics - Page 8 : comparemela.com

Context Therapeutics CEO Marty Lehr notes progress towards the clinic with CTIM-76 in 2Q update

Context Therapeutics (NASDAQ:CNTX) CEO Marty Lehr takes Proactive s Stephen Gunnion through progress with the company s lead program, CTIM-76. Lehr.

Context Therapeutics Inc (CNTX) Misses Q2 EPS by 11c

Context Therapeutics Inc (CNTX) Misses Q2 EPS by 11c
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Claudin 6 (CLDN6) T Cell engagers for CLDN6-positive solid tumors

Context Therapeutics Inc (NASDAQ:CNTX) Short Interest Update

Context Therapeutics Inc. (NASDAQ:CNTX – Free Report) was the target of a large decline in short interest in the month of June. As of June 15th, there was short interest totalling 115,000 shares, a decline of 54.6% from the May 31st total of 253,300 shares. Currently, 0.8% of the company’s shares are short sold. Based […]

Context Therapeutics Inc (NASDAQ:CNTX) Short Interest Up 153 3% in May

Context Therapeutics Inc. (NASDAQ:CNTX – Get Rating) was the target of a large growth in short interest in May. As of May 31st, there was short interest totalling 253,300 shares, a growth of 153.3% from the May 15th total of 100,000 shares. Approximately 1.7% of the company’s stock are short sold. Based on an average […]

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.